Amanote Research

Amanote Research

    RegisterSign In

The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer

OncoImmunology - United States
doi 10.4161/onci.25997
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyAllergyImmunology
Date

October 1, 2013

Authors
Sandra DemariaClaire Vanpouille-BoxSilvia C FormentiSylvia Adams
Publisher

Informa UK Limited


Related search

Metformin as an Adjuvant in Breast Cancer Treatment

SAGE Open Medicine
Medicine
2019English

Bisphosphonates as Adjuvant Therapy for Breast Cancer

Women's Health
Medicine
2006English

Progress in Adjuvant Chemotherapy for Breast Cancer: An Overview

BMC Medicine
Medicine
2015English

Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination Against Retroviral Infection

PLoS ONE
Multidisciplinary
2013English

Better Compliance With Hypofractionation vs. Conventional Fractionation in Adjuvant Breast Cancer Radiotherapy

Strahlentherapie und Onkologie
Nuclear MedicineRadiologyImagingOncology
2017English

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

JAMA - Journal of the American Medical Association
Medicine
2006English

Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity

English

Intraoperative Radiotherapy (IORT) as Boost in Breast Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy